These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 935212)

  • 21. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB; Moore KE
    Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
    [No Abstract]   [Full Text] [Related]  

  • 22. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T; Arnt J; Hyttel J
    Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
    Bakke OM; Scheline RR
    J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of benserazide on the levels of pineal 5-hydroxytryptamine, melatonin synthesising enzymes and serum melatonin.
    Ho AK; Smith JA
    Biochem Pharmacol; 1982 Jul; 31(13):2251-5. PubMed ID: 6889864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
    Hingtgen JN; Hendrie HC; Aprison MH
    Pharmacol Biochem Behav; 1984 Mar; 20(3):425-8. PubMed ID: 6608737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central versus peripheral effects on temperature preference and body temperature following alteration of 5-HT in maturing mice.
    Goodrich C; Lechner R; Slone W
    Physiol Behav; 1989 Aug; 46(2):203-9. PubMed ID: 2602460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the brain monoaminergic systems relating to ejaculation. III) Further study by using a peripheral decarboxylase inhibitor.
    Kimura Y; Miyamoto A; Tadano T; Harada T; Kisara K
    Andrologia; 1980; 12(4):354-9. PubMed ID: 7191642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of Ro 15-4513 on the behavioral actions of ethanol in an operant reaction time task and a conflict test.
    Koob GF; Percy L; Britton KT
    Pharmacol Biochem Behav; 1988 Nov; 31(3):757-60. PubMed ID: 3251257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
    Geissbühler F; Widmer J
    J Clin Chem Clin Biochem; 1976 Nov; 14(11):543-7. PubMed ID: 1003116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
    Kikta DC; Threatte RM; Barney CC; Fregly MJ; Greenleaf JE
    Pharmacol Biochem Behav; 1981 Jun; 14(6):889-93. PubMed ID: 6973156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Ro 15-4513 on schedule-controlled responding of pigeons.
    Delaney D; Schlinger H; Poling A
    Pharmacol Biochem Behav; 1989 Aug; 33(4):777-80. PubMed ID: 2616597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.
    Dwoskin LP; Sparber SB
    J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of eseroline on schedule-controlled behavior in the rat.
    Liu WF
    Pharmacol Biochem Behav; 1991 Apr; 38(4):747-51. PubMed ID: 1871191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the behavioral effects of carbon monoxide by reinforcement contingencies.
    Ator NA
    Neurobehav Toxicol Teratol; 1982; 4(1):51-61. PubMed ID: 7070569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine blocks disruptive and discriminative stimulus effects of quipazine.
    Friedman RL; Sanders-Bush E; Barrett RL
    Eur J Pharmacol; 1984 Oct; 106(1):191-3. PubMed ID: 6529966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat.
    Commissaris RL; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Oct; 13(4):601-3. PubMed ID: 7433492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants.
    Bizot JC; Thiébot MH; Le Bihan C; Soubrié P; Simon P
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1144-51. PubMed ID: 3418513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.